Motion Sickness Severity and Sensorimotor Performance
The Relationship of Balance, Proprioception, Coordination, and Reaction Time Measurements With Motion Sickness Severity in Individuals With Motion Sickness: A Cross-Sectional Study
1 other identifier
observational
41
0 countries
N/A
Brief Summary
Background: Motion sickness (MS) is a common syndrome characterized by autonomic and behavioral symptoms, such as nausea and dizziness, resulting from exposure to motion stimuli. Its pathophysiology is closely linked to sensory conflict and postural instability theories. While previous studies suggest that postural control, proprioception, and reaction times are affected in individuals susceptible to MS, there is a lack of comprehensive, comparative research evaluating all these parameters concurrently within the same cohort using standardized methods. Objective: This study aims to systematically measure balance, proprioceptive sensitivity, coordination, and reaction time parameters, and quantitatively analyze their relationship with motion sickness severity. Methodology: In this prospective, cross-sectional study, at least 41 participants aged 18-40 with motion sickness will be recruited. Participants will undergo motion sickness susceptibility and severity grading using the Motion Sickness Susceptibility Questionnaire Short Form (MSSQ-SF) and the Graybiel Scale. Objective assessments will include static and dynamic balance testing (ProKin®), knee joint position sense (Clinometer app), manual dexterity and dynamic balance coordination (Nine-Hole Peg Test, Tandem Walk, Romberg Test), and upper/lower extremity reaction time measurements (BlazePod system).
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for all trials
Started Jun 2026
Shorter than P25 for all trials
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
May 26, 2026
CompletedStudy Start
First participant enrolled
June 1, 2026
CompletedFirst Posted
Study publicly available on registry
June 2, 2026
CompletedPrimary Completion
Last participant's last visit for primary outcome
August 2, 2026
ExpectedStudy Completion
Last participant's last visit for all outcomes
August 5, 2026
June 26, 2026
June 1, 2026
2 months
May 26, 2026
June 23, 2026
Conditions
Outcome Measures
Primary Outcomes (3)
Motion Sickness Severity (Graybiel Score)
Used to grade the clinical severity of acute motion sickness symptoms (including nausea, cold sweating, increased salivation, and dizziness) following a randomized chair-rotation provocation protocol. 0 (Minimum) to 50 points (Maximum). Higher scores indicate greater symptom severity, representing a worse clinical outcome (scores of 16 or above designate frank sickness).
1 hour
Static Balance
Evaluated objectively using the ProKin® computerized balance system. Participants stand on the platform under conditions: double-leg with eyes open.
1 hour
Dynamic Balance Performance
Evaluated using the ProKin® system.
1 hour
Secondary Outcomes (4)
Knee Joint Proprioception
1 hour
Nine-Hole Peg Test (9HPT) Completion Time
1 hour
Tandem Walk Test Error Count
1 hour
Visual Reaction Time
1 hour
Interventions
Participants will undergo a standardized battery of sensorimotor assessments, including static/dynamic balance tracking, knee joint position sense testing, manual dexterity/coordination tasks, and upper/lower extremity reaction time measurements, alongside a controlled motion sickness provocation session using a randomized chair-rotation protocol."
Eligibility Criteria
The study population consists of adult individuals aged between 18 and 40 years who exhibit susceptibility to motion sickness.
You may qualify if:
- Individuals aged between 18 and 40 years.
- Diagnosed with motion sickness according to the Motion Sickness -Susceptibility Questionnaire Short Form (MSSQ-SF).
- Normal hearing acuity.
- No history of acute or chronic vestibular disease, other than motion sickness.
- Normal or corrected-to-normal vision.
- Adequate physical capability to fully perform the measurement protocols, including balance, proprioception, coordination, and reaction time tests.
You may not qualify if:
- Presence of any physical or orthopedic problem that could interfere with testing.
- History of acute or chronic instability, unsteadiness, or vertigo.
- Severe visual impairment.
- History of prior ear surgery.
- Presence of any neurological condition or disorder.
- History of migraines.
- Current use of medications that could affect balance or vestibular function (e.g., vestibular suppressants, sedatives).
- Use of alcohol or psychoactive substances within the last 48 hours prior to testing.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Dr. Assistant Professor
Study Record Dates
First Submitted
May 26, 2026
First Posted
June 2, 2026
Study Start
June 1, 2026
Primary Completion (Estimated)
August 2, 2026
Study Completion (Estimated)
August 5, 2026
Last Updated
June 26, 2026
Record last verified: 2026-06